Retatrutide is an investigational (not yet widely approved) metabolic drug being developed for obesity, type 2 diabetes, and related metabolic disorders. It is notable for being the first major therapy designed to activate three hormone pathways at once: GLP-1, GIP, and glucagon receptors.

Because of this “triple-agonist” design, it is sometimes described as a next-generation weight management medication.

Product Name: Retatrutide

CAS No.: 2381089-83-2

Assay: ≥99%

Molecular Weight: 4731.33g/mol

Molecular Formula: C221H342N46O68

Appearance: White Powder

Storage Condition: Sealed, stored at -20°C for long-term storage

Package Quantity: 1g,10g,100g or according to the customer’s requests

Packing material: Aluminium foil bag or plastic bottle

Any products on our website are sold for research and laboratory use only.